Skip to content

Interest coverage at other companies

IAR
Integra LifeSciencesIART
-5.4×-5.6×
MiMedx Group logo
MiMedx GroupMDXG
11.9×
Artivion logo
ArtivionAORT
1.5×+1.1×
Axogen logo
AxogenAXGN
-1.5×
LeMaitre Vascular logo
LeMaitre VascularLMAT
14.1×-21.4×
Vericel logo
VericelVCEL
24.8×+21.4×

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Organogenesis Holdings Inc.’s reported figures.

Based on trailing twelve months.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed November 9, 2023, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s interest coverage?
Organogenesis Holdings Inc. (ORGO) reported interest coverage of 13.3× in Q3 2023.
How has Organogenesis Holdings Inc.'s interest coverage changed year-over-year?
Organogenesis Holdings Inc.'s interest coverage increased by 15.8% year-over-year, from 11.5× to 13.3×.
What is the long-term trend for Organogenesis Holdings Inc.'s interest coverage?
Over 2 years (2020 to 2022), Organogenesis Holdings Inc.'s interest coverage has grown at a 113.5% compound annual growth rate (CAGR), from 2.4× to 10.9×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.